We applied CellChat to investigate differences in potential cell–cell communication between AML and healthy groups, categorizing cells based on CD63 expression to distinguish exosome-activated (CD63+) and non-activated (CD63−) populations [42]. This evidence concerns the gene CD63 and acute myeloid leukemia.